This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Patient Education/ Health Literacy  • Neoplasms  • Diagnosis  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

How Far Can We Go?

Arch Dermatol. 1999;135:339-340.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MANY GROUPS have for the past 20 years followed the lead of the Queensland Melanoma Programme, Australia, in promoting what is defined as secondary melanoma prevention.¹ This is recognition of melanoma at the earliest possible time, on the assumption that early diagnosis and prompt treatment will reduce mortality.

Available evidence suggests that, in its earliest stages, when malignant melanomas are thinner than 1.5 mm, they may still be confined to the primary site and are therefore potentially curable. Thus, the aim is to minimize delay between recognizable tumor growth and excision on the assumption that there is a link between them, and that short delay is associated with thinner tumors.

This assumption was first made by the Queensland Melanoma Programme in their early detection of melanoma campaigns, which appear to have been extremely successful. At present, although the incidence of melanoma continues to rise in Queensland, melanoma mortality rates are . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Melanoma and Tumor Thickness: Challenges of Early Diagnosis
Marie Aleth Richard, Jean Jacques Grob, Marie Françoise Avril, Michèle Delaunay, Xavier Thirion, Pierre Wolkenstein, Pierre Souteyrand, Brigitte Dreno, Jean Jacques Bonerandi, Sophie Dalac, Laurent Machet, Jean Claude Guillaume, Jacqueline Chevrant-Breton, Catherine Vilmer, François Aubin, Bernard Guillot, Marie Beylot-Barry, Catherine Lok, Nadia Raison-Peyron, and Philippe Chemaly
Arch Dermatol. 1999;135(3):269-274.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Detection of Thick Melanomas in the United States: Beware of the Nodular Subtype
Demierre et al.
Arch Dermatol 2005;141:745-750.
ABSTRACT | FULL TEXT